Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Selling, General & Administrative
Glenmark Life Sciences Ltd
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Selling, General & Administrative
-₹2.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Selling, General & Administrative
-₹118.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Selling, General & Administrative
-₹43.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-11%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Selling, General & Administrative
-₹93.1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-17%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Selling, General & Administrative
-₹30.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-12%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Selling, General & Administrative
-₹19.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-11%
|
See Also
What is Glenmark Life Sciences Ltd's Selling, General & Administrative?
Selling, General & Administrative
-2.6B
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Selling, General & Administrative amounts to -2.6B INR.
What is Glenmark Life Sciences Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
2%
Over the last year, the Selling, General & Administrative growth was 46%. The average annual Selling, General & Administrative growth rates for Glenmark Life Sciences Ltd have been 12% over the past three years , 2% over the past five years .